Clinical Trial Update: Nicotinamide Adenine Dinucleotide and Skeletal Muscle Metabolic Phenotype [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update exploring nicotinamide adenine dinucleotide and skeletal muscle metabolic phenotype in aging. Status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aging

Snippet

Sponsor: University of Birmingham | Conditions: Aging | Phase 2 | Status: UNKNOWN